Traws Pharma, Inc. (TRAW)

Traws Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	16.39	20.82	38.76	55.07	19.03	22.73
Cash & Cash Equivalents	16.39	20.82	38.76	55.07	19.03	22.73
Cash Growth	-52.10%	-46.28%	-29.62%	189.46%	-16.29%	33.92%
Receivables	0.02	0.02	0.03	0.03	0.04	0.1
Other Current Assets	1.75	1.82	0.56	0.33	0.72	0.65
Total Current Assets	18.15	22.66	39.35	55.43	19.78	23.47
Property, Plant & Equipment	0.02	0.02	0.02	0.04	0.05	0.05
Other Long-Term Assets	0	0	0	0.01	0.15	0.15
Total Long-Term Assets	0.02	0.02	0.03	0.05	0.2	0.2
Total Assets	18.17	22.68	39.37	55.48	19.99	23.67
Accounts Payable	6.57	5.62	3.86	2.76	4.83	4.27
Deferred Revenue	2.96	3.02	3.24	3.47	3.7	3.92
Other Current Liabilities	-0.11	0.58	0.94	-0.11	1.49	0.1
Total Current Liabilities	9.42	9.22	8.05	6.12	10.02	8.29
Other Long-Term Liabilities	2.74	2.79	3.02	3.24	3.79	3.81
Total Long-Term Liabilities	2.74	2.79	3.02	3.24	3.79	3.81
Total Liabilities	12.16	12.01	11.06	9.36	13.81	12.1
Retained Earnings	-487.61	-482.63	-463.68	-444.72	-428.56	-403.4
Comprehensive Income	-0.03	-0.02	-0.03	-0.01	0.01	-0.02
Shareholders' Equity	6.02	10.67	28.31	46.12	6.18	11.57
Net Cash / Debt	16.39	20.82	38.76	55.07	19.03	22.73
Net Cash / Debt Growth	-52.10%	-46.28%	-29.62%	189.46%	-16.29%	33.92%
Net Cash Per Share	0.78	0.99	1.85	3.27	1.64	23.70
Working Capital	8.73	13.44	31.3	49.32	9.76	15.18
Book Value Per Share	0.29	0.51	1.35	2.74	0.53	12.07

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).